美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Gemphire Therapeutics Inc.

0.3000

0.0000

成交量：- -

成交额：- -

市值：446.17万

市盈率：-0.31

高：0.3000

开：0.3000

低：0.3000

收：0.3000

52周最高：1.49

52周最低：0.2380

股本：1,487.24万

流通股本：1,028.40万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.9678

每股收益(LYR):-1.7121

净资产收益率：-280.97%

总资产收益率：-44.90%

市净率：2.27

市盈率(LYR):-0.18

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Gemphire Therapeutics Inc.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.gemphire.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Gemphire Therapeutics Inc.于2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)这个名字注册成立。公司是一家临床阶段的生物制药公司，致力于将用于治疗血脂异常，即一种会增加威胁生命的心血管疾病风险的严重的疾病疗法的研究开发和商业化。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/GEMP/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GEMP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GEMP\",,,,,undefined,":{"symbol":"GEMP","market":"US","secType":"STK","nameCN":"Gemphire Therapeutics Inc.","latestPrice":0.3,"timestamp":1577739600000,"preClose":0.3,"halted":8,"volume":0,"delay":0,"floatShares":10283980,"shares":14872411,"eps":-0.967778,"marketStatus":"盘后交易","change":0,"latestTime":"12-22 19:25:05 EST","open":0.3,"high":0.3,"low":0.3,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.967778,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1766451600000},"marketStatusCode":4,"symbolChange":{"newSymbol":"NRBO","executeDate":"2019-12-31"},"adr":0,"adrRate":0,"listingDate":1470369600000,"exchange":"NASDAQ","adjPreClose":0.3,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GEMP\",,,,,undefined,":{"symbol":"GEMP","floatShares":10283980,"roa":"-44.90%","roe":"-280.97%","lyrEps":-1.712137,"shares":14872411,"dividePrice":0,"high":0.3,"amplitude":0,"preClose":0.3,"low":0.3,"week52Low":0.238,"pbRate":"2.27","week52High":1.485,"institutionHeld":0,"latestPrice":0.3,"eps":-0.967778,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.967778,"open":0.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GEMP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-12-31","symbol":"GEMP","oldSymbol":"GEMP","newSymbol":"NRBO","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1577768400000},{"market":"US","date":"2019-12-31","symbol":"GEMP","type":"split","dateTimestamp":1577768400000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2019-08-09","symbol":"GEMP","fiscalQuarterEnding":"2019/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1565323200000,"reportTimeType":"","actualEps":-0.2},{"market":"US","date":"2019-05-09","symbol":"GEMP","fiscalQuarterEnding":"2019/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1557374400000,"reportTimeType":"","actualEps":-0.27},{"market":"US","date":"2019-03-15","symbol":"GEMP","fiscalQuarterEnding":"2018/12","expectedEps":-0.39,"name":null,"time":"","type":"earning","dateTimestamp":1552622400000,"reportTimeType":"","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GEMP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GEMP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.gemphire.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Gemphire Therapeutics Inc.于2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)这个名字注册成立。公司是一家临床阶段的生物制药公司，致力于将用于治疗血脂异常，即一种会增加威胁生命的心血管疾病风险的严重的疾病疗法的研究开发和商业化。","exchange":"NASDAQ","name":"Gemphire Therapeutics Inc.","nameEN":"Gemphire Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GEMP\",market:\"US\",,,undefined,":null}}